Summary
The aim of the study was to analyze changes in myocardial angiotensinogen gene expression and myocardial angiotensin converting enzyme activity in slowly progressing low-output failure. In adult, male Wistar rats, acute ventricular tachypacing by 610 to 620 impulses per minute lowered enddiastolic external diameter of the left ventricle by 2.6% (p < 0.01), but did not lower cardiac output or abolish coronary reserve, since left-ventricular subendocardial blood flow of paced rats increased under dipyridamole (2 mg/kg i.v.) by 56% (p < 0.01). Systemic neuroendocrine activation and ventricular dilation without enlargement of ventricular mass developed subsequent to chronic tachypacing, but left-ventricular diameter during pacing never exceeded the value of sham rats on sinus rhythm. After 2 weeks, cardiac output was lowered by 14% (p < 0.001), cardiopulmonary blood volume was elevated by 30% (p < 0.001), and angiotensinogen mRNA and angiotensin converting enzyme activity in ventricular myocardium were doubled. We conclude that conditions for an enhanced intracardiac angiotensin II-formation developed in tachypacing-induced heart failure, but that enhanced . systolic wall stress or myocardial ischemia are not required for this activation of the local cardiac reninangiotensin system.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aceto JF, Baker KM (1990) (Sari)-Angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 258:H806-H813
Admiraal PJJ, Derkx FHM, Danser AHJ, Pietermann H, Schalekamp MADH (1990) Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 15:44–55
Armstrong PW, Stopps TP, Ford SE, De Bold AJ (1986) Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 74:1075–1084
Bugge-Asperheim B, Leraand S, Kid F (1969) Local dimensional changes of the myocardium measured by ultrasonic technique. Scand J Clin Lab Invest 24:361–371
Campbell DJ (1985) The site of angiotensin production. J Hypertens 3:199–207
Campbell DJ (1987) Circulating and tissue angiotensin systems. J Clin Invest 79:1–6
Campbell DJ, Kladis A (1990) Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man. J Hypertens 8:165–172
Derkx FHM, Verhoeven RP, Wenting GJ, Man Int Veld AJ, Schalenkamp MA (1978) Renal release of active and inactive renin in essential and renovascular hypertension. Clin Sci Mol 55:S129-S132
Dibner-Dunlap ME, Thames MD (1989) Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ Res 65:1526–1535
Drexler H, Hänze J, Finckh M, Lu W, Just H, Lang RE (1989) Atrial natriuretic peptide in a rat model of cardiac failure. Circulation 79:620–633
Drexler H, Lindpaintner K, Lu W, Schieffer B, Ganten D (1989) Transient increase in the expression of cardiac angiotensinogen in a rat model of myocardial infarction and failure. Circulation 80:11–459
Dzau VJ (1989) Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens 7:933–936
Flaim SF, Nellis SH, Toggart EJ, Drexler H, Kanda K, Newman ED (1984) Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rats. J Pharmacol Methods 11:1–39
Hauptman JG, deJong GK, Blasko KA, Chaudry IH (1989) Measurement of hepatocellular function, cardiac output, effective blood volume and oxygen saturation in rats. Am J Physiol 257:R439-R444
Hellmann W, Suzuki F, Ohkubo H, Nakanishi S, Ludwig G, Ganten D (1988) Angiotensinogen gene expression in extrahepatic rat tissues: application of a solution hybridization assay. Naunyn-Schmiedebergs Arch Pharmacol 338:327–331
Holtz J, Bassenge E, Kinadeter H, Kolin A (1981) Increased effective vascular compliance and venous pooling of intravascular volume during sustained venodilation in conscious dogs. Basic Res Cardiol 76:657–669
Holtz J, Sommer O, Bassenge E (1987) Inhibition of sympathoadrenal activity by atrial natriuretic factor in dogs. Hypertension 9:350–354
Holtz J, Finckh M (1989) Attenuation of sympathetic activity and of tachycardia-induced heart failure progression by converting enzyme inhibition: a model for the analysis of preventive mechanisms in developing heart failure? In: MacGregor GA, Sever P (eds) Current advances in ACE inhibition. Churchill Livingstone, Edinburgh 1989, pp 287–290
Holtz J, Münzel T, Sommer O, Bassenge E (1989) Sympathoadrenal inhibition by atrial natriuretic peptide is not attenuated during development of congestive heart failure in dogs. Circulation 80:1862–1869
Hori M, Iwai K, Iwakura K, Sato H, Kitabatake A (1989) Angiotensin II stimulates protein synthesis in neonatal rat cardiomyocytes through enhanced Na/H exchange. Circulation 80:11–450
Huang H, Baussant T, Reade R, Michel JB, Corvol P (1989) Measurement of angiotensin II concentration in rat plasma: pathophysiological applications. Clin Exp Hypertens A 11:1535–1548
Katoh Y, Komuro I, Shibasaki Y, Yamaguchi H, Yazaki Y (1989) Angiotensin II induces hypertrophy and oncogene expression in cultured rat heart myocytes. Circulation 80:11–450
Katz AM (1990) Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med 322:100–110
Klett C, Hellmann W, Suzuki F, Nakanishi S, Ohkubo H, Ganten D, Hackenthal E (1988) Induction of angiotensinogen mRNA in hepatocytes by angiotensin II and glucocorticoids. Clin Exp Hypertens A 10:1009–1022
Lindpaintner K, Jin M, Wilhelm MJ, Suzuki F, Linz W, Schoelkens BA, Ganten D (1988) Intracardiac generation of angiotensin and its physiologic role. Circulation 77:18–23
Lindpaintner K, Jin M, Niedermaier N, Wilhelm MJ, Ganten D (1990) Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ Res 67:564–573
Linz W, Schölkens BA, Ganten D (1989) Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens A 11:1325–1350
Loudon M, Bing RF, Thurston H, Swales JD (1983) Arterial wall uptake of renal renin and blood pressure control. Hypertension 5:629–634
Marban E, Koretsune Y (1990) Cell calcium, oncogenes, and hypertrophy. Hypertension 15:652–658
Mizelle HL, Hall JE, Montani JP (1989) Role of renal nerves in the control of sodium excretion in chronic congestive heart failure. Am J Physiol 256:171084–171093
Mizuno K, Tani M, Niimura S, Hashimoto S, Satoh A, Shimamoto K, Inagami T, Fukuchi S (1989) Direct evidence for local generation and release of angiotensin II in human vascular tissue. Biochem Biophys Res Comm 165:457–463
Moe GW, Stopps TP, Angus C, Forster C, De Bold AJ, Armstrong PW (1989) Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol 13:173–179
Nadal-Ginard B, Mahdavi V (1989) Molecular basis of cardiac performance. J Clin Invest 84:1693–1700
Neyses L, Vetter H, Sukhathme VP, Williams RS (1989) Angiotensin II induces expression of the early growth response gene 1 in isolated adult cardiomyocytes. Circulation 80:11–450
Okamura T, Miyazaki M, Inagami T, Toda N (1986) Vascular renin angiotensin system in two kidney, one clip hypertensive rats. Hypertension 8:560–565
Pagani M, Vatner SF, Baig H, Franklin DL, Patrick T, Manders WT, Quinn P, Sherman A (1978) Measurement of multiple simultaneous small dimensions and study of arterial pressure dimension relations in conscious animals. Am J Physiol 234:H610-H617
Riegger GAJ, Liebau G, Holzschuh M, Witkowski D, Steilner H, Kochsiek K (1984) Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am J Cardiol 53:614–618
Riegger GAJ, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K (1988) Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation 77:398–406
Saito H, Nakamaru M, Ogihara T, Rakugi H, Kumahara Y, Shimamoto K, Miyazaki M, Inagami T (1989) Renin inhibitor and converting enzyme inhibitors suppress vascular angiotensin II. Hypertension 13:749–753
Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH (1990) Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest 86:1913–1920
Schwartz K, Mercadier JJ, Swynghedauw B, Lompré AM (1988) Modifications of gene expression in cardiac hypertrophy. Heart Failure 4:154–163
Sealey JE, Atlas SA, Laragh JH (1983) Prorenin in plasma and kidney. Fed Proc 42:2681–2689
Simpson P (1985) Stimulation of hypertrophy of cultured neonatal rat heart cells through an α1-adrenergic aladrenergic receptor and induction of beating through an α1- and β1-adrenergic receptor interaction: evidence for independent regulation of growth and beating. Circ Res 56:884–894
Tang SS, Stevenson L, Dzau VJ (1990) Endothelial renin-angiotensin pathway. Circ Res 66:103–108
Thurston H, Swales JD, Bing RF, Hurst BC, Marks ES (1979) Vascular renin-like activity and blood pressure maintenance in the rat: studies of the effect of changes in sodium balance, hypertension and nephrectomy. Hypertension 1:643–649
Wang W, Chen JS, Zucker IH (1990) Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 81:1959–1966
Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek N (1987) Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 75:857–867
Xiang JZ, Linz W, Becker H, Ganten D, Lang RE, Schölkens B, Unger T (1985) Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol 113: 215–223
Zierhut W, Zimmer HG (1989) Significance of myocardial α- and β-adrenoceptors in catecholamine induced cardiac hypertrophy. Circ Res 65:1417–1425
Zimmermann BG (1981) Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci 60:343–348
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Finckh, M., Hellmann, W., Ganten, D. et al. Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats. Basic Res Cardiol 86, 303–316 (1991). https://doi.org/10.1007/BF02191528
Issue Date:
DOI: https://doi.org/10.1007/BF02191528